| scholarly article | Q13442814 |
| P2093 | author name string | Masaki Yamamoto | |
| David Baron | |||
| Hirofumi Nagai | |||
| Hitoshi Kandori | |||
| Keiichiro Sato | |||
| Yasuyuki Awasaki | |||
| Zen-Yo Tanakamaru | |||
| P433 | issue | 3 | |
| P304 | page(s) | 234-244 | |
| P577 | publication date | 2011-01-19 | |
| P1433 | published in | Toxicology and Applied Pharmacology | Q2446974 |
| P1476 | title | Suppressive effects of acid-forming diet against the tumorigenic potential of pioglitazone hydrochloride in the urinary bladder of male rats | |
| P478 | volume | 251 |
| Q27002540 | Cancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysis |
| Q58815362 | Carcinogenicity of some drugs and herbal products |
| Q36499766 | DNA damage in exfoliated cells and histopathological alterations in the urinary tract of mice exposed to cigarette smoke and treated with chemopreventive agents |
| Q38651175 | Diabetes drugs and the incidence of solid cancers: a survey of the current evidence. |
| Q38092275 | Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus? |
| Q38058381 | Examining the safety of PPAR agonists - current trends and future prospects |
| Q91671552 | Functional network analysis of gene-phenotype connectivity based on pioglitazone |
| Q28829259 | Generalized enrichment analysis improves the detection of adverse drug events from the biomedical literature |
| Q36549041 | Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling. |
| Q38061184 | Peroxisome proliferator-activated receptor agonists and bladder cancer: lessons from animal studies |
| Q36505700 | Pharmacological Modulation of Lung Carcinogenesis in Smokers: Preclinical and Clinical Evidence |
| Q38721611 | Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis |
| Q38282651 | Pioglitazone has a dubious bladder cancer risk but an undoubted cardiovascular benefit |
| Q45974480 | Pioglitazone prescription increases risk of bladder cancer in patients with type 2 diabetes: an updated meta-analysis. |
| Q37205860 | Relationships between pulmonary micro-RNA and proteome profiles, systemic cytogenetic damage and lung tumors in cigarette smoke-exposed mice treated with chemopreventive agents. |
| Q44980532 | Risk of bladder cancer in diabetic patients treated with rosiglitazone or pioglitazone: a nested case–control study |
| Q38122640 | Scientific Evidence and Controversies About Pioglitazone and Bladder Cancer: Which Lessons Can Be Drawn? |
| Q84108503 | Stay vigilant: a glitazone (pioglitazone) can hide a glitazar! |
| Q36001145 | The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study |
| Q34065266 | Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis |
| Q34315432 | Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. |
| Q35466765 | Use of noninsulin anti diabetics for prevention and treatment of cancer- narrative review article |
Search more.